by Admin | Apr 8, 2024 | Blog
NGS test for colorectal cancer to guide targeted therapy FollowFollow Colorectal cancer (CRC) can develop from germline genetic mutations inherited from family or somatic mutations developed later in life. Our Optiseq™ colorectal cancer NGS for mutation detection...
by Admin | Apr 3, 2024 | Blog
Detection of ROS1, RET, and ALK fusions in non-small cell lung cancer FollowFollow ROS1 (c-ros oncogene 1), RET (rearranged during transfection), and ALK (anaplastic lymphoma kinase) are receptors of tyrosine kinases that play important roles in cell growth and...
by Admin | Feb 20, 2024 | Press Releases
Press release DiaCarta’s RadTox™ Test to Monitor Tumor Response Receives Medicare Coverage FollowFollow DiaCarta, a leading molecular diagnostics company personalizing patient care through liquid biopsy, proudly announced that its revolutionary RadTox™ test,...
by Admin | Feb 14, 2024 | Blog
Who should be tested for VEXAS syndrome? FollowFollow As a relatively newly discovered autoinflammatory disease, VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is associated with mutations in the UBA1 gene. Diagnosis of the disease relies on...
by Admin | Feb 6, 2024 | Blog
Genetic Testing for the VEXAS Syndrome FollowFollow Diagnosis of the VEXAS syndrome improves medical management of the disease and provides more effective treatment of the disease, although there is no cure currently. The diagnosis relies on the VEXAS syndrome genetic...
Recent Comments